Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Nanopharmaceuticals reviews advances in the drug delivery field via nanovehicles or nanocarriers that offer benefits like targeted therapy and serves as a single dose magic bullet for multiple drug delivery with improved drug efficiency at a lower dose, transportation of the drug across physiological barriers as well as reduced drug-related toxicity. The chapters are written by a diverse group of international researchers from industry and academia.
The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.
Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.
Other volumes in the Expectations and Realities of Multifunctional Drug Delivery Systems book series:
Delivery of Drugs, Volume 2, 9780128177761
Drug Delivery Trends, Volume 3, 9780128178706
Drug Delivery Aspects, Volume 4, 9780128212226
- Encompasses functional aspects of nanocarriers
- Discusses Intellectual Property landscapes of micro-nano drug carriers
- Contains in-depth investigation of specific aspects of drug delivery systems
Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers
- Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical properties
J.R. CAMPOS, P. SEVERINO, A. SANTINI, A.M. SILVA, RANJITA SHEGOKAR, S.B. SOUTO, AND E.B. SOUTO
2. Role of nanocarriers and their surface modification in targeting delivery of bioactive compounds
HENI RACHMAWATI, ATSARINA LARASATI, ANNIS CATUR ADI, AND RANJITA SHEGOKAR
3. Polymeric nanomicelles as versatile tool for multidrug delivery in chemotherapy
KOBRA ROSTAMIZADEH AND VLADIMIR P. TORCHILIN
4. Nanoparticulate systems for wound healing
MAHA NASR, RIHAM I. EL-GOGARY, HEND ABD-ALLAH, AND MONA ABDEL-MOTTALEB
5. Solid dispersions: technologies used and future outlook
N.B. JADAV AND A. PARADKAR
6. Nanotoxicity: the impact of increasing drug bioavailability
7. Nanoparticle-based vaccines: opportunities and limitations
DIANA DIAZ-ARÉVALO AND MINGTAO ZENG
8. Lipid nanocarriers for delivery of poorly soluble and poorly permeable drugs
ANÐELKA B. KOVACEVIC
9. Nose-to-brain drug delivery: an alternative approach for effective brain drug targeting
AMIT ALEXANDER, MUKTA AGRAWAL, MAHAVIR BHUPAL CHOUGULE, SHAILENDRA SARAF, AND SWARNLATA SARAF
10. Trends in the intellectual property (IP) landscape of drug delivery systems: 30 years of growth and evolution
AMANDA STARLING-WINDHOF, ASUR SRINIVASAN, TINA TOMEO, ANNE MARIE CLARK, AND PETER MATTEI
- No. of pages:
- © Elsevier 2020
- 16th January 2020
- Paperback ISBN:
- eBook ISBN:
Dr. Ranjita Shegokar holds a PhD degree in Pharmaceutical Technology from the SNDT University, India, and has been postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at Free University of Berlin, Germany. Since last 8 years she is working in the pharmaceutical industry in various technical/R&D roles. Currently, she serves as Director of Pharma Business Unit at Capnomed GmbH, Germany. She has authored many research articles, book chapters, and presented several research papers in conferences. She has filed multiple patent application in area of drug delivery and drug targeting. She received several national and international awards for her research. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions and role of excipients in delivery systems.
Director, Pharma Business Unit, Capnomed GmbH, Germany
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.